Anticoagulant Citrate Dextrose (ACD-A)
These highlights do not include all the information needed to use ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A safely and effectively. See full prescribing information for ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A. ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A Sterile Fluid Polyolefin Container (solution bag) Clear Overwrap Initial U.S. Approval: 2012
0130d7c8-d067-4528-beb7-166559c33be9
HUMAN PRESCRIPTION DRUG LABEL
Jul 25, 2023
Terumo BCT, Ltd
DUNS: 233649834
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Dextrose Monohydrate, sodium citrate, unspecified form, and Citric Acid Monohydrate
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
Drug Labeling Information
HOW SUPPLIED SECTION
16 HOW SUPPLIED/STORAGE AND HANDLING
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) SOLUTION A is a clear sterile solution supplied in non-pyrogenic polyolefin solution bags. Each solution bag is individually wrapped in a clear overwrap. Each clear overwrap is then individually foil wrapped. Neither the clear overwrap nor the foil overwrap can be considered a sterile barrier. This product has a sterile fluid pathway only.
|
SIZE |
CATALOG NUMBER |
NDC NUMBER | |
|---|---|---|---|
|
50 mL |
40820 |
Case: |
14537-820-03 |
|
Foil: |
14537-820-01 | ||
|
Bag: |
14537-820-00 |
STORAGE
Store up to 25 °C [See USP Controlled Room Temperature].
Avoid excessive heat. Protect from freezing.